BrainStorm Cell Therapeutics Shares Rise 7.2% on NurOwn Stud

By Denny Jacob BrainStorm Cell Therapeutics shares rose 7.2% to 35 cents following a submitted special protocol assessment request to the Food and Drug...

Related Keywords

Chaim Lebovits , Denny Jacob , Drug Administration , Storm Cell Therapeutics , Chief Executive Chaim , Article Normal , Financial Performance , Share Price Movement Disruptions , Corporate Industrial News , Political General News , Gene Cell Therapy , Health , Medical Treatments Procedures , Equity Markets , Commodity Financial Market News , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , C Amp Ampe Industry News Filter , Synd , Us10501e2019 , Bcli , Share Price Movement , Disruptions , Corporate , Industrial News , Political , General News , Gene , Cell Therapy , Medical Treatments , Procedures , Commodity , Financial Market News ,